Latest Headlines

  1. Bristol Spinout Launches With More Than £700,000 To Deliver Blood Test For Hidden Vascular Disease 9/14/2026

    Dimension Biotechnologies is developing a novel blood test designed to reveal biochemical signs of disease within the microvasculature – the vast network of microscopic blood vessels responsible for delivering oxygen and nutrients throughout the body.

  2. EMPE Diagnostics To Unveil CircuLOK Product Range At NATCON 2026, Expanding Access To TB Drug-Resistance Diagnostics 9/10/2026

    EMPE Diagnostics AB today announced it will unveil the CircuLOK product range at the 81st National Conference on Tuberculosis and Chest Diseases (NATCON 2026), taking place 1-4 October in Patiala, India.

  3. AddLife Acquires Unicam Sistemas Analíticos Lda 9/9/2026

    AddLife has acquired Unicam Sistemas Analíticos, a leading Portuguese distributor of advanced analytical laboratory equipment. The company will be included within AddLife’s Business Area Labtech.

  4. GENFIT Highlights Long-Term Commercial Opportunity For Its MASH Diagnostics Technology 9/9/2026

    ​GENFIT, a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today highlights the long-term commercial opportunity associated with NIS4 and next-generation NIS2+, its proprietary non-invasive NISTM diagnostic technologies aimed to identify patients with “at-risk MASH”.

  5. Sysmex Europe And Cytek® Biosciences Collaborate To Expand Access To Advanced Clinical Flow Cytometry 9/9/2026

    Sysmex Europe SE, a leader in diagnostic and healthcare solutions, and Cytek Biosciences, Inc. (Nasdaq: CTKB), a leader in spectral flow cytometry technology, today announced a strategic collaboration across over a dozen European countries to enhance clinical flow cytometry workflows and expand access to innovative diagnostic solutions.

  6. Bionano Laboratories Announces New York State Department Of Health Approval Of Lab Developed Tests Based On Optical Genome Mapping 9/8/2026

    Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that the New York State Department of Health (NYSDOH) has approved the use of optical genome mapping (OGM)-based LDTs for the clinical evaluation of samples from patients suspected of various genetic disorders including reproductive disorders and hematologic malignancies at University of Rochester Medicine (URochester Medicine), marking a significant milestone in the adoption of OGM for clinical cytogenomics.

  7. Eppendorf Launches New Refrigerated Centrifuge 5811 R 9/8/2026

    Eppendorf is launching the new Centrifuge 5811 R, a refrigerated, multipurpose benchtop centrifuge designed to support a wide range of laboratory workflows. It builds on the proven performance and versatility of the Centrifuge 5810 R.

  8. Molecular Instruments Announces HCR Gold IF For Multiplex Protein Imaging On Biocare Medical's ONCORE Pro X 9/8/2026

    Molecular Instruments(MI), founded by the inventor of HCR technology, today announced the availability of HCR Gold IF on Biocare Medical’s ONCORE Pro X, a fully open automated slide staining system for research laboratories.

  9. Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory And Biomarker Capabilities For Clinical Trials 9/8/2026

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa. Financial terms of the transaction were not disclosed.

  10. Anitoa Announces Secure Cloud Connectivity For Its Portable qPCR Instruments, Unlocking Advanced Biosurveillance And AI Integration 9/8/2026

    Anitoa Systems, LLC., a Silicon Valley biotechnology company and market leader in rapid, portable molecular testing hardware, today announced a major advancement in point-of-care molecular testing: the integration of comprehensive cloud connectivity and enterprise-grade security features into its highly popular line of portable qPCR instruments.